Heart failure pathway launch

Posted:

Cardiac specialists from across the region are gathering this month to learn more about Cheshire and Merseyside’s heart failure pathway.

The Cheshire and Merseyside Cardiac Board will showcase the integrated end-to-end pathway which will improve access and outcomes for people with heart failure.

The pathway has been developed with patients, GPs, cardiologists, heart failure specialist nurses, pharmacists, cardiac rehab teams and other specialists (palliative care, kidney specialists) across Cheshire and Merseyside, integrating primary, secondary and tertiary care.

Date: Thursday, 25 November 2021

Time: 8.45am – 5pm

Venue: Haydock Park Racecourse, Newton-le-Willows, WA12 0HQ

Booking: Register your physical or virtual attendance on Eventbrite

Funded by Novartis and AstraZeneca*, the event is being run in partnership with Cheshire and Merseyside Health and Care Partnership and heart failure charity, Pumping Marvellous.

It will be chaired by Dr Joe Mills, Consultant Cardiologist at Liverpool Heart and Chest Hospital / Clinical Network Lead Cheshire and Merseyside Cardiac Board, and Jonathan Develing, Director of Strategic Partnerships, Liverpool Heart and Chest Hospital.

Sessions will be hosted by expert speakers from across the region and will include:

  • Patient stories
  • The role of heart failure multidisciplinary teams in relation to Cheshire and Merseyside pathway
  • The role of primary care in relation to Cheshire and Merseyside pathway
  • The role of other specialists in heart failure in relation to Cheshire and Merseyside pathway

Six Royal College of Practitioners CPD points have been applied for.

Attendance at Haydock Park is limited to 100 delegates and must be booked in advance through Eventbrite. Live streaming and recording options will also be available.

*Novartis and AstraZeneca have no input into the conference content.

Translate »